Haoxi Health (HAO) names independent director Chuanjie Hu to key committees

Rhea-AI Filing Summary

Haoxi Health Technology Limited reported a change in its board of directors. On March 6, 2026, director Jianbing Zhang resigned from the board for personal reasons, and the company stated that his resignation did not involve any disagreement over operations, policies, or practices.

The board appointed Chuanjie Hu as a new director effective the same day and determined he meets the “independence” requirements of Nasdaq and Rule 10A-3. Mr. Hu will chair the nominating and corporate governance committee and serve on the compensation and audit committees, and will not receive compensation for his board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Accepted by SEC EDGAR 03/06/2026 - 04:15 PM Learn about SEC filing dates

FAQ

What board changes did Haoxi Health Technology Limited (HAO) disclose?

Haoxi Health Technology Limited reported that director Jianbing Zhang resigned for personal reasons on March 6, 2026. The board simultaneously appointed Chuanjie Hu as a new director, assigning him key committee roles, including chairing the nominating and corporate governance committee and serving on the compensation and audit committees.

Why did Jianbing Zhang resign from Haoxi Health Technology Limited’s board?

Jianbing Zhang resigned as a director of Haoxi Health Technology Limited on March 6, 2026, citing personal reasons. The company specifically noted that his resignation did not result from any disagreement with the company regarding its operations, policies, or practices, helping limit concerns about internal conflicts or governance issues.

Who is the new independent director appointed by Haoxi Health (HAO)?

Haoxi Health appointed Chuanjie Hu as a new director effective March 6, 2026. The board determined he meets Nasdaq and Rule 10A-3 independence standards, and he will chair the nominating and corporate governance committee while also serving on the compensation committee and the audit committee for the company.

What is the professional background of Haoxi Health director Chuanjie Hu?

Chuanjie Hu has extensive experience in business management. Since November 2018, he has been General Manager of Beijing Chuanna Impression Culture Co., Ltd. Previously, from 2009 to 2018, he served as Business Group Manager at Tingyi (Cayman Islands) Holding Corp., focusing on business development and strategic planning.

Is Haoxi Health’s new director Chuanjie Hu independent under Nasdaq rules?

Yes. Haoxi Health’s board determined that new director Chuanjie Hu satisfies the independence requirements under Nasdaq’s corporate governance rules and Rule 10A-3 under the Securities Exchange Act of 1934. This allows him to serve on the audit, compensation, and nominating and corporate governance committees in independent roles.

Will Haoxi Health (HAO) pay compensation to director Chuanjie Hu?

According to the company, Haoxi Health entered into an offer letter with director Chuanjie Hu under which he will not receive compensation for his services as a board member. Despite this, he will hold significant responsibilities as committee chair and member across key governance and oversight committees.

Does Haoxi Health’s new director have related-party ties or family relationships?

The company stated that director Chuanjie Hu has no family relationship with any Haoxi Health director or executive officer. It also disclosed he has not been involved in any transaction with the company in the past two years that would require disclosure under Item 404(a) of Regulation S-K.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2026

Commission File Number: 001-41933

Haoxi Health Technology Limited

(Translation of registrant’s name into English)

Room 801, Tower C, Floor 8, Building 103

Huizhongli, Chaoyang District

Beijing, China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒           Form 40-F ☐

Change of Directors

On March 6, 2026, Mr. Jianbing Zhang, a director of Haoxi Health Technology Limited’s (the “Company”), resigned from his position due to personal reasons, effective immediately.

The resignation of Mr. Jianbing Zhang was not the result of any disagreements with the Company on any matter related to the operations, policies, or practices of the Company.

The board of directors (“Board”) of the Company appointed Mr. Chuanjie Hu as a director of Board, effective on March 6, 2026. The Board determined that Mr. Chuanjie Hu satisfies the “independence” requirements under the corporate governance rules of The Nasdaq Stock Market LLC and Rule 10A-3 under the Securities Exchange Act of 1934, as amended. Mr. Hu will serve as the chairman of the nominating and corporate governance committee, a member of the compensation committee, and a member of the audit committee. The biographical information of Mr. Chuanjie Hu is set forth below.

Mr. Chuanjie Hu, aged 40, has extensive experience in business management and corporate operations. Since November 2018, Mr. Hu has served as the General Manager of Beijing Chuanna Impression Culture Co., Ltd., a China-based company engaged in cultural and business development activities, where he is responsible for overseeing the company’s business development strategies and overall operational management. From September 2009 to August 2018, Mr. Hu served as Business Group Manager at Tingyi (Cayman Islands) Holding Corp., a multinational food and beverage company, where he was responsible for business development initiatives and strategic planning of the company’s business operations. Mr. Hu received a bachelor’s degree in International Economics and Trade from Huaiyin Institute of Technology in 2009.

Mr. Chuanjie Hu does not have a family relationship with any director or executive officer of the Company and has not been involved in any transaction with the Company during the past two years that would require disclosure under Item404(a) of Regulation S-K.

The Company entered into an offer letter (the “Offer Letter”) with Mr. Chuanjie Hu. He will not receive compensation for his services as a director of the Board. The Offer Letter is filed hereto as Exhibit 10.1.

1

EXHIBIT INDEX

Number		Description of Exhibit
10.1		The Offer Letter, dated March 6, 2026 by and between the Company and Chuanjie Hu

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Haoxi Health Technology Limited
	By:	/s/ Zhen Fan
		Zhen Fan
		Chief Executive Officer
Date: March 6, 2026

3

Filing Exhibits & Attachments

1 document

Agreements & Contracts

• EX-10.1 THE OFFER LETTER, DATED MARCH 6, 2026 BY AND BETWEEN THE COMPANY AND CHUANJIE HU 30.0 KB